Munich Reinsurance Co Stock Corp in Munich acquired a new position in Celestica, Inc. (NYSE:CLS – Free Report) (TSE:CLS) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 15,084 shares of the technology company’s stock, valued at approximately $5,499,000.
Other institutional investors have also recently made changes to their positions in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in Celestica in the 4th quarter worth approximately $28,000. Ascentis Independent Advisors bought a new position in Celestica in the 1st quarter worth approximately $29,000. Swiss RE Ltd. purchased a new stake in Celestica during the 4th quarter valued at approximately $29,000. Cullen Frost Bankers Inc. purchased a new stake in Celestica during the 4th quarter valued at approximately $30,000. Finally, Sittner & Nelson LLC bought a new stake in shares of Celestica during the fourth quarter valued at approximately $31,000. Hedge funds and other institutional investors own 67.38% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities analysts have recently commented on CLS shares. JPMorgan Chase & Co. boosted their target price on shares of Celestica from $445.00 to $485.00 and gave the stock an “overweight” rating in a report on Wednesday, July 29th. UBS Group upgraded shares of Celestica from a “neutral” rating to a “buy” rating and lifted their price target for the company from $410.00 to $430.00 in a report on Monday, August 24th. Scotiabank started coverage on shares of Celestica in a research note on Tuesday, August 11th. They issued a “sector outperform” rating and a $500.00 price target on the stock. Bank of America reissued a “buy” rating on shares of Celestica in a report on Wednesday, July 29th. Finally, Zacks Research upgraded Celestica from a “hold” rating to a “strong-buy” rating in a research report on Friday, June 26th. One investment analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $439.81.
Celestica Stock Up 1.0%
NYSE CLS opened at $312.84 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.68 and a current ratio of 1.23. The company has a market capitalization of $35.97 billion, a P/E ratio of 32.52 and a beta of 2.04. Celestica, Inc. has a one year low of $227.00 and a one year high of $474.02. The stock has a 50 day moving average price of $327.47 and a 200-day moving average price of $335.77.
Celestica (NYSE:CLS – Get Free Report) (TSE:CLS) last posted its earnings results on Monday, July 27th. The technology company reported $2.54 earnings per share for the quarter, beating analysts’ consensus estimates of $2.29 by $0.25. The firm had revenue of $4.68 billion during the quarter, compared to analyst estimates of $4.30 billion. Celestica had a net margin of 7.16% and a return on equity of 39.96%. Celestica’s revenue for the quarter was up 62.4% compared to the same quarter last year. During the same period last year, the firm posted $1.39 earnings per share. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. As a group, equities analysts predict that Celestica, Inc. will post 10.71 EPS for the current fiscal year.
Insider Activity
In related news, CFO Mandeep Chawla sold 16,117 shares of the stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $369.32, for a total value of $5,952,330.44. Following the completion of the transaction, the chief financial officer owned 65,444 shares of the company’s stock, valued at approximately $24,169,778.08. This trade represents a 19.76% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Robert Mionis sold 23,496 shares of Celestica stock in a transaction dated Thursday, August 13th. The stock was sold at an average price of $362.39, for a total value of $8,514,715.44. Following the completion of the transaction, the chief executive officer owned 23,396 shares of the company’s stock, valued at approximately $8,478,476.44. This represents a 50.11% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 356,553 shares of company stock worth $135,238,444 over the last 90 days. Corporate insiders own 1.10% of the company’s stock.
Celestica Profile
Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.
The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.
Featured Articles
- Five stocks we like better than Celestica
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica, Inc. (NYSE:CLS – Free Report) (TSE:CLS).
Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.
